I cannot provide an accurate gene function summary for TAT (tyrosine aminotransferase) based on the provided abstracts. The PubMed abstracts supplied exclusively address HIV-1 TAT (transactivator of transcription) protein, which is a viral protein unrelated to the human TAT gene on chromosome 16. The abstracts discuss HIV-1 replication, neurotoxicity, and protein transduction mechanisms—none of which pertain to tyrosine aminotransferase function. Based on the NCBI and UniProt information provided (not from abstracts), TAT catalyzes the first committed step of tyrosine catabolism, converting L-tyrosine to p-hydroxyphenylpyruvate using 2-oxoglutarate as a cosubstrate. This enzyme is primarily expressed in the cytosol and participates in tyrosine and glutamate metabolism. Mutations in TAT cause tyrosinemia type 2 (Richner-Hanhart syndrome), characterized by ocular and skin manifestations. To provide a properly cited summary grounded in PubMed evidence, abstracts specifically addressing human tyrosine aminotransferase function, regulation, and disease associations would be required.